Viridian Therapeutics Stock News & Updates

[WKN: A2QMUH | Symbol: VRDN]
Viridian Therapeutics

Viridian Therapeutics (VRDN): Stifel Sees 198% Price Potential - Convincing Long-Term Data From the Phase 3 Study THRIVE!

Analysts' Top 5 Price Targets of May 26, 2025

Glaukos Corp. [US3773221029]: Piper Sandler reaffirms Buy rating with a price target of $165 (70% upside...

  • ‹
  • 1
  • ›